WAYFIND-R: Delivering a high-quality real-world data (RWD) global registry of patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS)

被引：0
|
作者：
Le Tourneau, Christophe [1 ]
Hackshaw, Allan [2 ]
Blay, Jean-Yves [3 ]
Geissler, Jan [4 ]
Turnbul, Clare [5 ]
Perret, Camille [6 ]
Skatkova, Olga [6 ]
von Meyenn, Martina [6 ]
Dienstmann, Rodrigo [7 ]
机构：
[1] Inst Curie, Paris, France
[2] UCL Canc Inst, London, England
[3] Ctr Leon Berard, Lyon, France
[4] Patvocates GmbH, Riemerling, Germany
[5] Inst Canc Res, London, England
[6] F Hoffmann La Roche Ltd, Basel, Switzerland
[7] Oncoclin Grp, Oncoclin Precis Med, Sao Paulo, Brazil
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4094
引用
收藏
页数：2
相关论文
共 29 条
  • [21] Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencing
    Souza, Gabriel Roman
    Abdalla, Ahmed
    Arora, Sukeshi
    Mahadevan, Daruka
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (03) : 643 - 649
  • [22] Changes over time in real-world next-generation sequencing (NGS) test use in patients (pts) with advanced non-small cell lung cancer (aNSCLC).
    Swaminathan, Akshay
    Stergiopoulos, Stella
    Snider, Jeremy
    Fisher, Virginia
    Castellanos, Emily
    Snow, Tamara
    Cho-Phan, Cheryl
    Comment, Leah
    Cunningham, Rachel
    McCusker, Margaret E.
    CANCER RESEARCH, 2021, 81 (13)
  • [23] Feasibility of Next-generation Sequencing of Liquid Biopsy (Circulating Tumor DNA) Samples and Tumor Tissue from Patients with Metastatic Prostate Cancer in a Real-world Clinical Setting in Germany
    Mandel, Philipp
    Hoeh, Benedikt
    Humke, Clara
    Doering, Claudia
    Wenzel, Mike
    Garcia, Cristina Cano
    Fuhr, Nina
    Koll, Florestan
    Fassl, Anne
    Tilki, Derya
    Steuber, Thomas
    Faull, Iris
    Jeroch, Jan
    Ebner, Silvana
    Schmitt, Christina
    Reis, Henning
    Koellermann, Jens
    Kokkaliaris, Konstantinos D.
    Demes, Melanie C.
    Chun, Felix K. H.
    Wild, Peter J.
    EUROPEAN UROLOGY FOCUS, 2024, 10 (02): : 339 - 345
  • [24] Real-world next-generation sequencing (NGS) and treatment (Tx) patterns in non-small cell lung cancer (NSCLC) patients (pts) with MET exon 14 skipping mutations (METex14)
    Le, X.
    Martinalbo, J.
    Holynskyj, A.
    Rhodes, W. C.
    Wu, W-H.
    Kim, J.
    Pretre, V.
    Ye, F.
    Morrissette, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S988 - S988
  • [25] Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data
    Ronan, Karine
    Jordan, Emmet
    Leonard, Christine
    Mcdermott, Ray
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 (03) : 1155 - 1161
  • [26] Genomic characterization and monitoring molecular response to treatment in African American (AA) advanced prostate cancer (PC) patients (pts) via next-generation sequencing (NGS): Real-world experience in a safety net hospital Oncology clinic.
    Khashab, Tamer
    Kaochar, Salma
    Le, Alexander D.
    Cohen, Samantha
    Noor, Attiya B.
    Dowst, Heidi
    Zarrin-Khameh, Neda
    Brooks, Michael A.
    Godoy, Guilherme
    Berezina, Maria A.
    Schwarzbach, Anna E.
    Scheurer, Michael E.
    Mims, Martha P.
    Mitsiades, Nicholas
    CANCER RESEARCH, 2021, 81 (13)
  • [27] Changes in non-small cell lung cancer (NSCLC) next-generation sequencing (NGS) rates after electronic health record (EHR) integration using large-scale, multi-institutional, real-world data.
    Matrana, Marc Ryan
    Mergler, Patrick
    Posteraro, Leo
    Chen, James Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Brain metastases (BM) and next-generation sequencing (NGS) timing: Real-world (RW) outcomes for patients (pts) with advanced non-small cell lung cancer (aNSCLC) and MET exon 14 skipping mutations (METex14)
    Le, Xiuning
    Robb, Stephen
    Caro, Nydia
    Doria, Simona
    Rhodes, Whitney C.
    Wu, Wen-Hsing
    Kim, Julia
    Pretre, Vincent
    Ye, Fen
    CANCER RESEARCH, 2022, 82 (12)
  • [29] Next-generation sequencing (NGS) results among hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC) patients treated with a CDK4 & 6 inhibitor: A retrospective observational study based on real-world data.
    Hamilton, Erika Paige
    Jansen, Valerie Malyvanh
    Smyth, Emily Nash Nash
    Schlauch, Daniel
    Carter, Gebra Cuyun
    Willard, Melinda D.
    Misch, Amanda
    Bowman, Lee
    Zhu, Yajun Emily
    McNeely, Samuel
    Lin, Aimee Bence
    Picard, Shaita
    Blackwell, Kimberly
    Burris, Howard A.
    Spigel, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
123